News

Sufjan Stevens Shares Rare Update on Health amid Guillain-Barré Syndrome Diagnosis: 'I’m in a State of Repair and Survival'
The indie singer-songwriter announced his diagnosis in 2023 with a photo of himself in a wheelchair Sufjan Stevens gave a ...
Nasdaq4d
Annexon, Inc. Presents Positive Real-World Evidence for Tanruprubart in Guillain-Barré Syndrome at 2025 PNS Annual Meeting
The oral presentation highlighted the benefits of tanruprubart in improving patient outcomes compared to current standard treatments for Guillain-Barré Syndrome (GBS), which lacks FDA-approved ...
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today ...
Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...